PMWC 2018 Silicon Valley Session Themes AllAI / Machine LearningImmunotherapyDx & RxEconomicsCancer CareClinical EnablementEmerging TechnologiesGenomic Data AnalysisNext-Generation SequencingBig DataMicrobiomeLiquid BiopsyMobile HealthBiomarker DevelopmentGovernment and Private InitiativesPatient PerspectiveShowcasesAll of Us Protecting your IO Intellectual Property Session Chair: Catherine M. Polizzi, Morrison & Foerster LLP Scalable NGS Infrastructure/Platforms Session Chair: Brady Davis, DNAnexus Accelerating Cancer Therapies and Exploiting Longitudinal Patient Data: Partnering to Achieve PM Session Chair: Keith R. Yamamoto, UCSF Clinical Applications of Circulating Tumor DNA Analysis Session Chair: Maximilian Diehn, Stanford Genetic Testing and Return of Results Session Chair: Christa Lese Martin, Geisinger Big Thoughts About Small Data Session Chair: Anil Sethi, Ciitizen Wellness and Aging Showcase Session Chair: Jennifer Lovejoy, Arivale Disruptive Approaches and Technologies in Personalized Medicine Session Chair: Stephane Budel, DeciBio Consulting Genomic Profiling Showcase Session Chair: Nick Lench, Congenica AACR Project GENIE: An International Cancer Registry Session Chair: Alexander S. Baras, Johns Hopkins Hospital How AI will Cure Cancer Session Chair: Marty Tenenbaum, Cancer Commons Internationally Standardized Assays to Monitor Treatment and Residual Disease Session Chair: Jeffrey Edward Miller, Invivoscribe Value-based Healthcare – Learning from Others Session Chair: R. Adams Dudley, UCSF PMWC 2018 Company Competition Session Chair: Pratima Rao, NanoDimension Developing Multimodal Strategies for Molecular Diagnostic Oncology Testing Session Chair: Maher Albitar, NeoGenomics What is the Clinical Utility of Liquid Biopsy Session Chair: Atul Sharan, CellMax Life Comprehensive Genome Analytics in Rare Disease Diagnostics & Discovery Session Chair: Nick Lench, Congenica Large Scale Sequencing and Genetics Initiatives Session Chair: Aris Baras, Regeneron Genetics Center Enabling Precision Medicine Through Automated Literature Analysis Session Chair: Mark Kiel, Genomenon Genetics to Therapeutics Session Chair: Aris Baras, Regeneron Genetics CenterCell-based Immunotherapies Session Chair: Jeffrey Bluestone, Parker Institute The Scalable Systems Framework for AI and Deep/Machine Learning Session Chair: Atul Butte, UCSF Expediting Patient Diagnosis and Treatment with AI and Machine Learning Session Chair: Eric Schadt, Sema4 Precision Medicine + Patients: A New Model Session Chair: Andrew Schorr, Patient Power LLC Emerging Therapeutics Showcase Session Chair: Emmanuelle Charpentier, Max Planck Institute Biospecimens as Building Blocks for Precision Medicine Discovery Session Chair: Christopher Ianelli, iSpecimen CRISPR Technology – How It Has Changed Biological Research Session Chair: Emmanuelle Charpentier, Max Planck Institute Microbial Profiling Showcase Session Chair: Aeron Hammack, Epibiome Clinical Dx Showcase Session Chair: Giulia C. Kennedy, Veracyte Liquid Biopsy Showcase Session Chair: Andre Marziali, Boreal Genomics Informed Health Decisions Through Creating a Learning Ecosystem Session Chair: Kenneth J. Pienta, Johns Hopkins University School of Medicine Making RNA Analysis Routine in the Clinic Session Chair: Rebecca Brandes, Agilent Digital Health: From Hype and into the Real World Session Chair: Sanjeev Bhavnani, Scripps Health Marrying a Drug with Diagnostics Session Chair: Dan Snyder, Molecular MD All of Us: Building a Protocol for All – Ethical, Legal, and Social Implications Session Chair: Stephanie Devaney, NIH Bringing the Next Generation of IO Biomarkers to the Clinic Session Chair: Alessandra Cesano, Nanostring All of Us: Engaging Underrepresented Populations Session Chair: Dara Richardson-Heron, NIH All of Us: Breaking Down Data Silos – Data Sharing and EHR Interoperability Session Chair: Josh Denny, Vanderbilt University The State of Genomics Guided Clinical Decision Support Session Chair: Sean Scott, QIAGEN The Challenges and Rewards of Bringing AI into the Clinic for Health & Disease Management Session Chair: Chris Cournoyer, N-of-One From Target to Patient: How Machine Learning Can Deliver on the Promise of Value Session Chair: Diane Wuest, GNS Healthcare AI-driven Pre-clinical and Clinical Drug Design, Discovery, and Development Session Chair: Alex Zhavoronkov, Insilico Medicine, Inc Economic and Socio-political Aspects of Precision Medicine Session Chair: Kevin Knopf, Cancer Commons AI and Data Science Showcase Session Chair: Eric Schadt, Sema4 The Role Of Blockchain in Precision Medicine Session Chair: Kamaljit Behera, Frost & Sullivan Operating Molecular Tumor Board Session Chair: Lincoln Nadauld, Intermountain Healthcare Targeting the Tumor Microenvironment Session Chair: Jennifer A. Wargo, MD Anderson Total Cost Challenges of IO Care Session Chair: Howard L. McLeod, Moffitt Cancer Center Predictive Biomarkers in IO Session Chair: Ann Kapoun, OncoMed Challenges in Patient Selection Session Chair: Lawrence Fong, UCSF Status Quo of Therapeutic Discoveries Session Chair: Axel Hoos, GSK The Promises of Combination Therapies Session Chair: Amy Peterson, BeiGene Cancer Vaccines to Boost the Immune System Session Chair: Ugur Sahin, BioNTech AG Delivering Laboratory Reports That Translate into Clinical Actions for Oncologists Session Chair: Dwight Baker, Illumina Accelerating Clinical Next-Generation Sequencing: Navigating the Path to Reimbursement Session Moderator: Rebecca Hemenway, Edico Genome Strategies for Improving Patient Survivorship Session Chair: Jani Ahonala, Noona Healthcare Precision Radiation Therapy in Cancer Treatment Session Chair: Quynh-Thu Le, Stanford Health Care Immunotherapy Showcase Session Chair: Ira Mellman, Genentech Clinical & Research Tools Showcase Session Chair: Rob Monroe, Advanced Cell DiagnosticsSee Program Schedule ->
